Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis mdm2'

Search results for: 'research area apoptosis mdm2'

10 Items

per page
  1. Curcumin
    A3335 Curcumin
     1 Citation
    Target: Histone Deacetylases (HDACs)|Nrf2|Histone Acetyltransferases (HATs)|Tyrosinases
    Summary: Tyrosinase inhibitor
      ≥36.8 mg/mL
  2. Celastrol
    A2604 Celastrol
    Target: Proteasome
    Summary: Antioxidant, anti-inflammatory and immunosuppressive agent
      ≥22.55 mg/mL
  3. Bardoxolone
    A3220 Bardoxolone
    Target: COX|iNOS
    Summary: Once-a-day treatment for CKD
      ≥49.2 mg/mL
  4. ferritin heavy chain fragment [Multiple species]
    A1069 ferritin heavy chain fragment [Multiple species]
    Summary: Ferritin heavy chain fragment
      ≥107.7 mg/mL
  5. a-MSH, amide
    A1025 a-MSH, amide
    Summary: Melanocyte-stimulating hormones
      insoluble in EtOH; ≥10.44 mg/mL
  6. LEP (116-130) (mouse)
    A1024 LEP (116-130) (mouse)
    Summary: An antiobesity hormone
      insoluble in EtOH; ≥156 mg/mL
  7. Imiquimod hydrochloride
    B1186 Imiquimod hydrochloride
    Summary: Toll-like receptor 7 agonist
  8. Imiquimod maleate
    B1187 Imiquimod maleate
    Summary: Immune response modifier
      Soluble in DMSO
  9. MK 886
    B6684 MK 886
     1 Citation
    Summary: A FLAP and PPARα inhibitor, capable of inhibiting leukotriene biosynthesis and inducing apoptosis
      ≥15.1 mg/mL
  10. Tanshinone IIA
    N1846 Tanshinone IIA
    Target: AP-1|MAGL
    Summary: Antioxidant and anti-inflammatory reagent
      insoluble in EtOH; insoluble in H2O; ≥3.42 mg/mL

10 Items

per page